Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| XAIR | Beyond Air | $2.35 | $1.47 | 168.26% | 354.7M | $7.0M | $0.67$10.40 |
| AHMA | Ambitions Enterprise Management L.l.c | $11.13 | $5.85 | 110.79% | 38.3M | $156M | $4.00$18.20 |
| THH | TryHard | $45.30 | $22.20 | 96.10% | 396.5K | $1.2B | $4.00$46.04 |
| MRNO | Murano Global Investments Plc | $2.04 | $0.57 | 38.78% | 72.2K | $117M | $0.49$13.25 |
| YI | 111 | $5.04 | $1.39 | 38.08% | 395.9K | $18M | $2.48$11.35 |
| BCTX | BriaCell Therapeutics | $10.36 | $2.72 | 35.61% | 6.7M | $14M | $6.00$98.20 |
| PMAX | Powell Max | $2.39 | $0.59 | 32.59% | 18.6M | $5.2M | $1.56$18.00 |
| WOK | Work Medical Technology Group Ltd | $2.69 | $0.59 | 28.00% | 505K | $18K | $1.85$60,000.00 |
| MVO | Mv Oil Trust | $2.08 | $0.45 | 27.64% | 2.1M | $19M | $0.97$8.87 |
| IOTR | iOThree | $3.33 | $0.72 | 27.59% | 21.3M | $6.7M | $2.24$59.80 |
Related Articles
Featured Article
Down 80%, Should You Buy the Dip on Moderna?
Adria Cimino|Dec 19, 2025
Your decision on whether to invest now depends to some extent on your investment strategy.
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy
James Brumley|Nov 5, 2025
The bank's lead analyst recognizes the importance of getting in early with potentially game-changing drug development.
Could This Anti-Obesity Drug Biotech Be Poised to Soar in 2026?
Prosper Junior Bakiny|Oct 29, 2025
This stock has caught fire after some recent events, but how long will that last?
Advertisement
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?
Cory Renauer|Oct 26, 2025
The clinical-stage biotech is working on a new type of weight management drug.
Prediction: Moderna Will Soar Over the Next 5 Years. Here's 1 Reason Why.
Prosper Junior Bakiny|Oct 22, 2025
The biotech's innovative qualities will come in handy.
Should You Buy Moderna Right Now?
Thomas Niel|Oct 22, 2025
Shares could keep sliding, as Moderna's post-COVID pipeline has yet to reach a breakthrough.
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Thomas Niel|Oct 21, 2025
Don't try to catch a falling surgical knife.
Why Moderna Might Be a One-Hit Wonder
David Jagielski, CPA|Oct 15, 2025
Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines.
2 Beaten-Down Stocks to Buy and Hold for a Decade
Prosper Junior Bakiny|Sep 30, 2025
These biotechs should benefit from their innovative ways.
Is it Time to Dump Your Shares of Moderna?
Reuben Gregg Brewer|Sep 7, 2025
Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to stick around?
